GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atrion Corp (NAS:ATRI) » Definitions » 5-Year Yield-on-Cost %

Atrion (Atrion) 5-Year Yield-on-Cost % : 3.83 (As of Apr. 27, 2024)


View and export this data going back to 1972. Start your Free Trial

What is Atrion 5-Year Yield-on-Cost %?

Atrion's yield on cost for the quarter that ended in Dec. 2023 was 3.83.


The historical rank and industry rank for Atrion's 5-Year Yield-on-Cost % or its related term are showing as below:

ATRI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1   Med: 1.48   Max: 5
Current: 3.83


During the past 13 years, Atrion's highest Yield on Cost was 5.00. The lowest was 1.00. And the median was 1.48.


ATRI's 5-Year Yield-on-Cost % is ranked better than
67.52% of 311 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs ATRI: 3.83

Competitive Comparison of Atrion's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Atrion's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrion's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atrion's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Atrion's 5-Year Yield-on-Cost % falls into.



Atrion 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Atrion is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Atrion  (NAS:ATRI) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Atrion 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Atrion's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrion (Atrion) Business Description

Traded in Other Exchanges
N/A
Address
One Allentown Parkway, Allen, TX, USA, 75002-4211
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Executives
Preston G Athey director ONE ALLENTOWN PKWY, ALLEN TX 75002
David A Battat officer: President & CEO 2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103
Jeannette Bankes director ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Morgan Hugh J Jr director
Ronald Nicholas Spaulding director ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Cindy Ferguson officer: Officer/ CFO ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffery Strickland officer: Vice President & CFO
Emile A Battat director, officer: Chairman ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Stupp John P Jr director STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124
Roger F Stebbing director
Ronald N Spaulding director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Richard O Jacobson director ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002
Maley John H P director 6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377
Margaret Maxwell Zagel director C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532

Atrion (Atrion) Headlines

From GuruFocus

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-09-2022

Atrion Corporation Declares Quarterly Cash Dividend

By sperokesalga sperokesalga 05-23-2023

Atrion Reports Second Quarter 2023 Results

By Marketwired 08-08-2023

Atrion Corporation Increases Quarterly Cash Dividend by 10%

By GlobeNewswire GlobeNewswire 08-22-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 07-08-2022

Atrion Corporation Declares Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 05-24-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 06-18-2022

Atrion Reports First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 06-28-2022